SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kerala Ayurveda - Quaterly Results

13 Feb 2026 Evaluate
The Revenue for the quarter ended  December 2025 of Rs. 220.65 millions grew by 14.02 % from Rs. 193.52 millions.The Net Loss for the quarter ended December 2025 is Rs. -34.72 millions as compared to Net Loss of Rs. -0.82 millions of corresponding quarter ended December 2024Operating profit Margin for the quarter ended December 2025 slipped to -10.86% as compared to 4.98% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 220.65 193.52 14.02 609.20 533.44 14.20 726.89 680.36 6.84
Other Income 9.75 1.31 644.27 132.32 7.96 1562.31 51.71 30.07 71.97
PBIDT -10.86 4.98 -318.07 7.06 -7.94 -188.92 -74.16 68.05 -208.98
Interest 19.83 3.83 417.75 52.96 11.11 376.69 39.16 53.98 -27.45
PBDT -30.69 1.15 -2768.70 -45.90 -19.05 140.94 -113.32 14.07 -905.40
Depreciation 5.82 2.77 110.11 23.54 6.94 239.19 21.51 15.74 36.66
PBT -36.51 -1.62 2153.70 -69.44 -25.99 167.18 -134.83 -1.67 7973.65
TAX -1.79 -0.80 123.75 -1.39 -6.84 -79.68 2.98 -2.20 -235.45
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -34.72 -0.82 4134.15 -68.05 -19.15 255.35 -137.81 0.53 -26101.89
Equity 120.60 120.32 0.23 120.60 120.32 0.23 120.32 120.32 0.00
PBIDTM(%) -4.92 2.57 -291.26 1.16 -1.49 -177.86 -10.20 10.00 -202.00

Kerala Ayurveda Share Price

242.90 0.65 (0.27%)
17-Apr-2026 10:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1689.70
Dr. Reddys Lab 1222.80
Cipla 1234.50
Zydus Lifesciences 944.00
Lupin 2322.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×